Ian E. Krop
Yale Cancer Center(US)Yale University(US)Smilow Cancer Hospital(US)
Publications by Year
Research Areas
HER2/EGFR in Cancer Research, Advanced Breast Cancer Therapies, Breast Cancer Treatment Studies, Cancer Treatment and Pharmacology, Monoclonal and Polyclonal Antibodies Research
Most-Cited Works
- → Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer(2012)3,715 cited
- → 3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)(2016)2,058 cited
- → Trastuzumab Deruxtecan in Previously Treated HER2-Positive Breast Cancer(2019)1,885 cited
- → CDK4/6 inhibition triggers anti-tumour immunity(2017)1,483 cited
- → Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer(2019)1,275 cited
- → Incidence of Endocrine Dysfunction Following the Use of Different Immune Checkpoint Inhibitor Regimens(2017)1,039 cited